Literature DB >> 1772588

The measurement of bilirubin fractions in serum.

B T Doumas1, T W Wu.   

Abstract

Bilirubin fractions are measured by (1) the direct diazo reaction, (2) high-performance liquid chromatography (HPLC), (3) direct spectrophotometry, and (4) enzymatic methods. HPLC, which effects separation and quantitation of the four bilirubin fractions, is the method of choice, but impractical for routine use. A special application of direct spectrophotometry allows the measurement of unconjugated bilirubin and the sum of bilirubin conjugates. This approach, which provides essentially the same information as HPLC, unfortunately is available only in one clinical analyzer. The direct diazo reaction measures bilirubin conjugates plus delta-bilirubin, albeit not very accurately. Direct diazo methods that measure unconjugated bilirubin as direct could obscure the clinical diagnosis. At acid pH, enzymatic methods measure all direct reacting bilirubins, while at pH 10 only conjugated bilirubins are measured. Because the measurement of conjugated bilirubins is clearly more helpful than that of direct bilirubin in the differential diagnosis of jaundice, direct diazo methods should be replaced by methods specific for bilirubin conjugates.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1772588     DOI: 10.3109/10408369109106872

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  9 in total

1.  Photolysis of bilirubin in serum specimens exposed to room lighting.

Authors:  Nadja N Rehak; Stacey A Cecco; Glen L Hortin
Journal:  Clin Chim Acta       Date:  2007-10-02       Impact factor: 3.786

2.  Conjugated bilirubin as a reflex test for increased total bilirubin in apparently healthy population.

Authors:  Guo-Ming Zhang; Zhi-De Hu
Journal:  J Clin Lab Anal       Date:  2017-05-19       Impact factor: 2.352

3.  Biliary Atresia as a Disease Starting In Utero: Implications for Treatment, Diagnosis, and Pathogenesis.

Authors:  Krupa R Mysore; Benjamin L Shneider; Sanjiv Harpavat
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-10       Impact factor: 2.839

Review 4.  [Cholestasis and liver dysfunction in critical care patients].

Authors:  M Kredel; J Brederlau; N Roewer; C Wunder
Journal:  Anaesthesist       Date:  2008-12       Impact factor: 1.041

5.  Diagnostic Yield of Newborn Screening for Biliary Atresia Using Direct or Conjugated Bilirubin Measurements.

Authors:  Sanjiv Harpavat; Joseph A Garcia-Prats; Carlos Anaya; Mary L Brandt; Philip J Lupo; Milton J Finegold; Alice Obuobi; Adel A ElHennawy; William S Jarriel; Benjamin L Shneider
Journal:  JAMA       Date:  2020-03-24       Impact factor: 56.272

6.  Compartment-specific gene regulation of the CAR inducer efavirenz in vivo.

Authors:  H E Meyer zu Schwabedissen; S Oswald; C Bresser; A Nassif; C Modess; Z Desta; E T Ogburn; M Marinova; D Lütjohann; C Spielhagen; M Nauck; H K Kroemer; W Siegmund
Journal:  Clin Pharmacol Ther       Date:  2012-05-16       Impact factor: 6.875

7.  Fluorescent protein-based detection of unconjugated bilirubin in newborn serum.

Authors:  Sota Iwatani; Hajime Nakamura; Daisuke Kurokawa; Keiji Yamana; Kosuke Nishida; Sachiyo Fukushima; Tsubasa Koda; Noriyuki Nishimura; Hisahide Nishio; Kazumoto Iijima; Atsushi Miyawaki; Ichiro Morioka
Journal:  Sci Rep       Date:  2016-06-21       Impact factor: 4.379

Review 8.  Quantitative assessment of the multiple processes responsible for bilirubin homeostasis in health and disease.

Authors:  David G Levitt; Michael D Levitt
Journal:  Clin Exp Gastroenterol       Date:  2014-09-02

9.  Aggressive nutrition in extremely low birth weight infants: impact on parenteral nutrition associated cholestasis and growth.

Authors:  Andreas Repa; Ruth Lochmann; Lukas Unterasinger; Michael Weber; Angelika Berger; Nadja Haiden
Journal:  PeerJ       Date:  2016-09-20       Impact factor: 2.984

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.